Skip to main content
. 2021 Oct 21;13(21):5284. doi: 10.3390/cancers13215284

Figure 1.

Figure 1

Analysis of type I and type II IFN signaling gene expression of GBM patients’ tumors in the TCGA database and GSCs. (A,B) Heat maps of TCGA RNA-seq data sets of GBM tumors. The normalized gene level for RNA-seq data was analyzed separately for the hallmark genes representing type I and type II IFN-low and -high signaling in tumors. (C) Survival analysis of IFN-low and -high signaling of GBM patients. (D,E) Heat maps of the type I and type II IFN signaling genes in the RNA-seq data in a cohort of GSCs.